BN 04/20 06:04 *IGNORE: MYLAN COMMENTS REPORTED PREVIOUSLY
Mylan Says Fully Committed to Standalone Strategy, Perrigo Offer
2015-04-20 06:04:15.62 GMT
By Allison Connolly
(Bloomberg) -- Co. responds to media speculation with
regard to a potential bid for Mylan by Teva.
* Says co. has studied potential combo with Teva “for some
time"; says unlikely that any such combo could obtain anti-
trust regulatory clearances
* Says board would consider an offer made for Mylan
Link to Company News:{MYL US <Equity> CN <GO>}
Link to Company News:{TEVA IT <Equity> CN <GO>}
Link to Company News:{PRGO US <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editor responsible for this story:
Allison Connolly at +44-20-3525-7043 or
aconnolly4@bloomberg.net
2015-04-20 06:04:15.62 GMT
By Allison Connolly
(Bloomberg) -- Co. responds to media speculation with
regard to a potential bid for Mylan by Teva.
* Says co. has studied potential combo with Teva “for some
time"; says unlikely that any such combo could obtain anti-
trust regulatory clearances
* Says board would consider an offer made for Mylan
Link to Company News:{MYL US <Equity> CN <GO>}
Link to Company News:{TEVA IT <Equity> CN <GO>}
Link to Company News:{PRGO US <Equity> CN <GO>}
For Related News and Information:
First Word scrolling panel: {FIRST<GO>}
First Word newswire: {NH BFW<GO>}
To contact the reporter on this story:
Allison Connolly in London at +44-20-3525-7043 or
aconnolly4@bloomberg.net
To contact the editor responsible for this story:
Allison Connolly at +44-20-3525-7043 or
aconnolly4@bloomberg.net